{
    "pmcid": "8646660",
    "qa_pairs": {
        "What is the dissociation constant (K_D) of the monoclonal antibody FD20 when binding to the RBD of the SARS-CoV-2 Spike protein?": [
            "5.6 nM",
            "3.2 nM",
            "7.8 nM",
            "10.1 nM"
        ],
        "What is the significance of targeting conserved regions outside the receptor-binding motif (RBM) in antibody design?": [
            "To avoid escape mutants",
            "To enhance binding to ACE2",
            "To increase antibody solubility",
            "To improve antibody half-life"
        ],
        "What mechanism does FD20 use to neutralize the SARS-CoV-2 virus?": [
            "Inducing conformational changes that inhibit ACE2 binding",
            "Blocking the viral RNA replication process",
            "Inhibiting the viral protease enzyme",
            "Disrupting the viral lipid membrane"
        ],
        "What structural feature of the FD20-RBD complex is highlighted as beneficial for broad neutralization across variants?": [
            "FD20 targets a conserved epitope that is structurally constrained and less prone to mutations",
            "FD20 binds to a highly flexible region allowing for adaptation",
            "FD20 interacts with multiple epitopes simultaneously",
            "FD20 forms a covalent bond with the RBD"
        ],
        "Which SARS-CoV-2 variants does the monoclonal antibody FD20 show promise in neutralizing?": [
            "Alpha, Beta, Gamma, and Delta",
            "Epsilon, Zeta, Eta, and Theta",
            "Lambda, Mu, Iota, and Kappa",
            "Omicron, Sigma, Tau, and Upsilon"
        ]
    }
}